CVAI | Total N | No. of events (incident ratea) | Model 1 | Model 2 | Model 3 | |||
---|---|---|---|---|---|---|---|---|
 h (95% CI) | P value | HR (95% CI) | P value | HR (95% CI) | P value | |||
Normotension | ||||||||
 CVAIb | 2421 | 99 (5.87) | 1.27 (1.02–1.59) | 0.032 | 1.28 (1.02–1.60) | 0.035 | 1.32 (1.03–1.69) | 0.030 |
 Q1 | 910 | 23 (3.62) | Ref. |  |  |  |  |  |
 Q2 | 720 | 36 (7.18) | 1.91 (1.13–3.22) | 0.015 | 1.93 (1.14–3.27) | 0.014 | 1.83 (1.07–3.11) | 0.027 |
 Q3 | 516 | 25 (6.95) | 1.87 (1.06–3.30) | 0.030 | 1.92 (1.08–3.42) | 0.026 | 1.95 (1.09–3.50) | 0.025 |
 Q4 | 275 | 15 (7.90) | 2.11 (1.10–4.04) | 0.025 | 2.11 (1.08–4.10) | 0.028 | 2.18 (1.07–4.42) | 0.032 |
Prehypertension | ||||||||
 CVAIb | 1934 | 124 (9.25) | 1.42 (1.18–1.69) | < 0.001 | 1.44 (1.21–1.72) | < 0.001 | 1.45 (1.20–1.76) | < 0.001 |
 Q1 | 502 | 22 (6.31) | Ref. |  | Ref. |  | Ref. |  |
 Q2 | 501 | 26 (7.45) | 1.19 (0.67–2.09) | 0.557 | 1.25 (0.71–2.22) | 0.445 | 1.31 (0.73–2.35) | 0.372 |
 Q3 | 518 | 37 (10.33) | 1.66 (0.98–2.81) | 0.061 | 1.84 (1.07–3.17) | 0.027 | 1.77 (1.01–3.12) | 0.047 |
 Q4 | 413 | 39 (13.71) | 2.21 (1.31–3.73) | 0.003 | 2.38 (1.39–4.07) | 0.002 | 2.46 (1.38–4.38) | 0.002 |
Hypertension | ||||||||
 CVAIb | 2887 | 389 (19.68) | 1.19 (1.08–1.32) | 0.001 | 1.16 (1.04–1.29) | 0.006 | 1.05 (0.93–1.18) | 0.442 |
 Q1 | 398 | 35 (12.83) | Ref. |  | Ref. |  | Ref. |  |
 Q2 | 590 | 70 (17.40) | 1.27 (0.85–1.90) | 0.251 | 1.34 (0.89–2.03) | 0.164 | 1.32 (0.87–2.03) | 0.196 |
 Q3 | 777 | 102 (19.10) | 1.40 (0.96–2.06) | 0.084 | 1.44 (0.97–2.14) | 0.070 | 1.38 (0.92–2.08) | 0.125 |
 Q4 | 1122 | 182 (23.72) | 1.72 (1.20–2.47) | 0.003 | 1.66 (1.14–2.42) | 0.008 | 1.34 (0.90–2.01) | 0.150 |